Loading…
Role of Isoprenylation in Simvastatin-Induced Inhibition of Ovarian Theca-Interstitial Growth in the Rat
Statins are competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, a rate-limiting step of the mevalonate pathway. The pleiotropic effects of statins may be due to inhibition of cholesterol synthesis, as well as decreased availability of several biologically important intermediat...
Saved in:
Published in: | Biology of reproduction 2009-11, Vol.81 (5), p.850-855 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Statins are competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, a rate-limiting step of the mevalonate
pathway. The pleiotropic effects of statins may be due to inhibition of cholesterol synthesis, as well as decreased availability
of several biologically important intermediate components of the mevalonate pathway, including two substrates for isoprenylation
(farnesyl pyrophosphate [FPP] and geranylgeranyl pyrophosphate [GGPP]). Recently, we demonstrated statin-induced inhibition
of ovarian theca-interstitial cell proliferation in vitro, as well as reduction of testosterone levels in women with polycystic
ovary syndrome (PCOS). This study evaluates the relative contribution of inhibition of isoprenylation and/or cholesterol availability
to the modulation of theca-interstitial proliferation. Rat theca-interstitial cells were cultured in chemically defined media
with or without simvastatin, FPP, GGPP, squalene, and/or two membrane-permeable forms of cholesterol (25-hydroxycholesterol
and 22-hydroxycholesterol). Simvastatin inhibited DNA synthesis and the count of viable cells. The effects of simvastatin
were partly abrogated by FPP and GGPP but not by squalene or cholesterol. Inhibition of farnesyl transferase and geranylgeranyl
transferase reduced cell proliferation. The present findings indicate that simvastatin inhibits proliferation of theca-interstitial
cells, at least in part, by reduction of isoprenylation. These observations provide likely mechanisms explaining clinically
observed improvement of ovarian hyperandrogenism in women with PCOS. |
---|---|
ISSN: | 0006-3363 1529-7268 |
DOI: | 10.1095/biolreprod.109.078667 |